HCA Healthcare, Inc. (NYSE:HCA) is Eversept Partners LP’s 5th Largest Position

Eversept Partners LP boosted its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA) by 36.2% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 175,808 shares of the company’s stock after acquiring an additional 46,724 shares during the period. HCA Healthcare accounts for about 4.7% of Eversept Partners LP’s investment portfolio, making the stock its 5th largest holding. Eversept Partners LP owned about 0.07% of HCA Healthcare worth $52,769,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also made changes to their positions in the company. Whipplewood Advisors LLC purchased a new position in HCA Healthcare in the 4th quarter worth about $31,000. Tidemark LLC bought a new position in shares of HCA Healthcare during the 4th quarter valued at $36,000. Activest Wealth Management boosted its stake in shares of HCA Healthcare by 1,250.0% during the 4th quarter. Activest Wealth Management now owns 135 shares of the company’s stock worth $40,000 after acquiring an additional 125 shares during the last quarter. Pinnacle Bancorp Inc. grew its stake in shares of HCA Healthcare by 50.0% during the 4th quarter. Pinnacle Bancorp Inc. now owns 150 shares of the company’s stock valued at $45,000 after acquiring an additional 50 shares during the period. Finally, Eastern Bank bought a new stake in HCA Healthcare during the fourth quarter valued at about $62,000. Institutional investors own 62.73% of the company’s stock.

Wall Street Analysts Forecast Growth

HCA has been the subject of a number of research reports. Barclays lowered their target price on HCA Healthcare from $392.00 to $366.00 and set an “overweight” rating for the company in a research report on Monday, January 27th. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $405.00 price objective on shares of HCA Healthcare in a research note on Monday, January 27th. Truist Financial dropped their price target on shares of HCA Healthcare from $430.00 to $390.00 and set a “buy” rating for the company in a research note on Monday, January 6th. Guggenheim began coverage on HCA Healthcare in a research note on Wednesday, April 9th. They set a “neutral” rating for the company. Finally, Bank of America decreased their price objective on HCA Healthcare from $380.00 to $370.00 and set a “buy” rating for the company in a report on Monday, January 27th. One investment analyst has rated the stock with a sell rating, seven have assigned a hold rating, eleven have given a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $381.67.

HCA Healthcare Stock Performance

Shares of HCA stock opened at $317.93 on Tuesday. The firm has a market cap of $78.28 billion, a price-to-earnings ratio of 14.47, a PEG ratio of 1.10 and a beta of 1.48. The stock’s 50-day moving average is $328.66 and its two-hundred day moving average is $333.19. The company has a debt-to-equity ratio of 69.07, a quick ratio of 0.97 and a current ratio of 1.08. HCA Healthcare, Inc. has a 1 year low of $289.98 and a 1 year high of $417.14.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings results on Friday, January 24th. The company reported $6.22 EPS for the quarter, topping the consensus estimate of $6.03 by $0.19. HCA Healthcare had a return on equity of 586.47% and a net margin of 8.16%. During the same quarter in the previous year, the firm earned $5.90 earnings per share. Analysts predict that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Monday, March 31st. Investors of record on Monday, March 17th were issued a $0.72 dividend. The ex-dividend date was Monday, March 17th. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.91%. This is a boost from HCA Healthcare’s previous quarterly dividend of $0.66. HCA Healthcare’s dividend payout ratio is currently 13.11%.

Insider Buying and Selling at HCA Healthcare

In other news, SVP Jennifer Berres sold 9,533 shares of the business’s stock in a transaction that occurred on Friday, February 14th. The shares were sold at an average price of $322.59, for a total value of $3,075,250.47. Following the completion of the transaction, the senior vice president now owns 15,412 shares of the company’s stock, valued at $4,971,757.08. The trade was a 38.22 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. 1.30% of the stock is currently owned by insiders.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.